are glp 1 safe in pregnancy GLP-1 Receptor Agonists, Fertility Restoration, and Reproductive Safety Women of Reproductive Age: A Narrative Review A new study found reassuring

Most headaches associated with GLP-1 therapy appear during the dose-escalation phase, typically weeks 14, and resolve within 714 days of symptom onset

In a pilot study carried out around 20002001, Jeppesen and colleagues demonstrated that native GLP-2 administered twice daily for 35 days increased nutrient absorption, energy absorption, and weight gain in human subjects with SBS (66)

For people in this BMI range, GLP-1 therapy sometimes serves as a bridge to other interventions or as an alternative to bariatric surgery

PMCID: PMC3404899

Direct comparisons with existing GLP-1 receptor agonist therapies have not been conducted in head-to-head trials

Lancet 387 , 679690 (2016)